Literature DB >> 6313976

Serum angiotensin-converting enzyme. Alterations in hyperthyroidism, hypothyroidism, and subacute thyroiditis.

R C Smallridge, J Rogers, P S Verma.   

Abstract

Angiotensin-converting enzyme (ACE) activity was measured in the serum samples of 247 patients with varying thyroid states. In 60 hyperthyroid patients, the mean (+/- SD) ACE level of 29.5 +/- 9.7 units/mL was higher than in all other groups. The serum ACE level was 17.0 +/- 5.1 units/mL in 129 euthyroid subjects and differed from the level of 13.9 +/- 5.1 units/mL observed in 34 hypothyroid patients. Twenty-four patients receiving exogenous thyroid hormone had elevated serum thyroxine values. Their mean serum triiodothyronine level was in the normal range, and the mean ACE level did not differ from the euthyroid mean. The mean serum ACE level fell from 30.8 to 17.4 units/mL in 35 hyperthyroid patients studied before and after therapy. In 12 hypothyroid subjects, the mean serum ACE level rose from 11.6 to 15.8 units/mL after thyroid hormone replacement. In eight of ten patients with transient hyperthyroidism (subacute thyroiditis or painless thyrotoxic thyroiditis), their highest ACE levels were observed in the hyperthyroid or transition phase and fell progressively with the lowest values being recorded during the hypothyroid or early recovery phases. Thus, ACE activity may respond to thyroid hormone, and interpretation of serum ACE levels may require knowledge of the patient's thyroid status. Serum ACE may be useful as a probe for exploring peripheral thyroid hormone action.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6313976     DOI: 10.1001/jama.250.18.2489

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  7 in total

1.  Why is plasma angiotensin-converting enzyme activity elevated in hyperthyroidism?

Authors:  J E Roulston; A Gold; M Wright; S W Walker
Journal:  J R Soc Med       Date:  1987-08       Impact factor: 5.344

Review 2.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

3.  Comparison of serum angiotensin-converting enzyme in Graves' disease, toxic nodular goiter, and other thyroid conditions.

Authors:  H Czernobilsky; W Fiehn; R Ziegler
Journal:  Klin Wochenschr       Date:  1985-06-03

4.  Sodium ipodate increases triiodothyronine action in vivo.

Authors:  J H Hays; C Eil; R C Smallridge
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

Review 5.  Takotsubo cardiomyopathy associated with thyrotoxicosis: a case report and review of the literature.

Authors:  Myrto Eliades; Diala El-Maouche; Chitra Choudhary; Bruce Zinsmeister; Kenneth D Burman
Journal:  Thyroid       Date:  2013-07-25       Impact factor: 6.568

Review 6.  Thyroid Function During and After COVID-19 Infection: A Review.

Authors:  Sabri Artun Çabuk; Ayşe Zeynep Cevher; Yaşar Küçükardalı
Journal:  touchREV Endocrinol       Date:  2022-06-13

7.  The Association of Autoantibodies in Hyperthyroid Heart Disease Combined with Pulmonary Hypertension.

Authors:  Xiujuan Zhang; Lin Chen; Jianping Sheng; Chaoying Li; Yong He; WenXia Han
Journal:  Int J Endocrinol       Date:  2019-12-01       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.